- Presentations
- 4
- Markets
- 1
Rinvoq is a brand of Upadacitinib marketed by AbbVie, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Upadacitinib
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 15 mg extended-release tablet, 30 mg extended-release tablet, 45 mg extended-release tablet, 1 mg/mL oral solution
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rinvoq 15 mg extended-release tabletOral | AbbVie | US FDA | Available on request |
| Rinvoq 30 mg extended-release tabletOral | AbbVie | US FDA | Available on request |
| Rinvoq 45 mg extended-release tabletOral | AbbVie | US FDA | Available on request |
| Rinvoq 1 mg/mL oral solutionOral | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rinvoq
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.